<DOC>
	<DOCNO>NCT01594671</DOCNO>
	<brief_summary>Total knee arthroplasty often associate excessive postoperative bleeding due increase fibrinolysis . Hence , objective propose multicentre study determine peri-operative bleed compare application topical intravenous tranexamic acid habitual surgical haemostasis .</brief_summary>
	<brief_title>Tranexamic Acid Unilateral Total Knee Arthroplasty</brief_title>
	<detailed_description>Objectives : 1 . Principal : To assess topical intravenous tranexamic acid reduce less least 20 % blood loss respect habitual haemostasia patient , unilateral total knee arthroplasty . 2 . Secondary : To assess treatment safety . To perform cost- analysis . Methods : Randomized , multicentre , open parallel clinical trial three comparative group : Topical tranexamic acid , Intravenous tranexamic acid habitual haemostasia . In patient , single drainage 8mm inserted joint , remain closed one hour closure skin . NÂº participant centre : 2 . Random allocation centralise `` Hospital de la Santa Creu Sant Pau '' . Main outcome : Total blood loss ( mL ) post-operative period collect habitual drain system ) . Secondary outcome : Total blood loss ( mL ) hide blood calculate Nadler 's formula . Proportion patient blood transfusion , complication surgery wound , haemoglobin pre post-operative , unit blood transfuse , post-operative mortality , day hospital stay , safety intervention assessed.Direct cost analysis . Substudy : Pharmacokinetic study . The first 24 patient include `` Hospital de la Santa Creu Sant Pau '' tranexamic acid ( 12 topical- 12 intravenous ) determine : 1 . Plasmatic concentration tranexamic acid 2 . In topical intravenous tranexamic acid administration determine absorption rate drug bioavailability route : maximum plasma concentration , time reach Cmax , AUC , half-life .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Unilateral Total knee arthroplasty The patient consent participate Antecedent thromboembolic disease Patient cardiac alteration rhythm Patients valvular cardiac prosthesis Patients prothrombotic alteration coagulation Treatment anticonceptive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>primary knee arthroplasty</keyword>
	<keyword>tranexamic acid</keyword>
	<keyword>topical</keyword>
</DOC>